The “2023 IOL Market Report” examines the first-ever projected global decline in PC-IOL procedures and penetration in 2023—led by significantly reduced reimbursement in Japan and South Korea—and outlines the numerous countervailing positive and negative factors that will shape the IOL market over the next five years. One of these factors is refractive lens exchange, which has growing importance in driving premium IOL penetration.
The report also thoroughly examines the RxSight post-op adjustable IOL, which has become the fastest growing IOL in the world (though from a small base) with sales only in the United States.
In addition, the report adds new analysis into factors shaping growing adoption of immediate sequential bilateral cataract surgery (ISBCS) and same-day/next day cataract surgery.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.